Theratechnologies Receives FDA Approval of Prior Approval Supplement (PAS) for EGRIFTA SV® sBLA
Provided By GlobeNewswire
Last update: Apr 8, 2025
FDA action allows for unrestricted distribution of EGRIFTA SV®, removing uncertainty with respect to all manufactured batches
PAS approval follows recent FDA approval of new formulation, EGRIFTA WR™
Read more at globenewswire.comNASDAQ:THTX (9/5/2025, 8:00:01 PM)
3.27
+0.02 (+0.62%)
Find more stocks in the Stock Screener
